Pediatric Allergy Care Market Report 2026

Pediatric Allergy Care Market Overview

• Pediatric Allergy Care market size has reached to $5.22 billion in 2025 • Expected to grow to $7.78 billion in 2030 at a compound annual growth rate (CAGR) of 8.4% • Growth Driver: The Rise In Food Allergies In Children Driving The Growth Of The Pediatric Allergy Care Market Due To Increasing Prevalence And Need For Early Diagnosis And Management • Market Trend: Advancements In Prescription Oral Immunotherapy Expanding Early Childhood Peanut Allergy Treatment Options • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Pediatric Allergy Care Market?

Pediatric allergy care refers to the specialized medical practice focused on diagnosing, managing, and treating allergies in children, including food, environmental, and drug-related sensitivities. It aims to improve a child s quality of life by preventing allergic reactions, managing symptoms, and providing education for long-term care. The main care modalities of pediatric allergy care include drug therapy, allergy testing, pediatric immunotherapy, and telehealth and support. Drug therapy refers to the use of medications to manage and treat allergic conditions in children, helping control symptoms and prevent complications. They are provided for condition types including asthma, food allergy, allergic rhinitis, eczema, and anaphylaxis. The various applications involved are pediatric asthma care, food allergy diagnostics, allergic rhinitis and eczema integrated management, anaphylaxis prevention, and immunotherapy programs, and are used by several end users such as specialty allergy clinics, hospitals, diagnostic laboratories, telehealth providers, and other end users.

What Is The Pediatric Allergy Care Market Growth Forecast?

The pediatric allergy care market size is expected to see strong growth in the next few years. It will grow to $7.78 billion in 2030 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to expansion of telehealth services, adoption of ai-driven diagnostics, personalized treatment plans using genomics, integration of digital health platforms, demand for remote monitoring solutions. Major trends in the forecast period include telehealth expansion, personalized allergy management, remote symptom monitoring, integration with pediatric care platforms, digital prescription management.

Global Pediatric Allergy Care Market Segmentation

1) By Care Modality: Drug Therapy, Allergy Testing, Pediatric Immunotherapy, Telehealth And Support 2) By Condition Type: Asthma, Food Allergy, Allergic Rhinitis, Eczema, Anaphylaxis 3) By Application: Pediatric Asthma Care, Food Allergy Diagnostics, Allergic Rhinitis And Eczema Integrated Management, Anaphylaxis Prevention, Immunotherapy Programs 4) By End User: Specialty Allergy Clinics, Hospitals, Diagnostic Laboratories, Telehealth Providers, Other End Users Subsegments: 1) By Drug Therapy: Antihistamine Medications, Corticosteroid Medications, Leukotriene Receptor Antagonists, Biologic Therapies, Epinephrine Auto Injector Treatments 2) By Allergy Testing: Skin Prick Testing, Intradermal Testing, Patch Testing, Specific Immunoglobulin E Blood Testing, Oral Food Challenge Testing 3) By Pediatric Immunotherapy: Subcutaneous Immunotherapy, Sublingual Immunotherapy, Oral Immunotherapy, Epicutaneous Immunotherapy, Cluster Immunotherapy 4) By Telehealth And Support: Virtual Consultation Services, Remote Symptom Monitoring, Digital Prescription Management, Caregiver Education Programs, Mobile Health Application Support

What Is The Driver Of The Pediatric Allergy Care Market?

The rising incidence of food allergies in children is expected to propel the growth of the pediatric allergy care market going forward. Food allergies in children refer to immune system reactions that occur when a child’s body mistakenly identifies certain foods as harmful, triggering symptoms that can range from mild (such as hives or stomach upset) to severe (including anaphylaxis). The rising incidence of food allergies in children is due to the hygiene hypothesis, which suggests that reduced exposure to microbes in early childhood leads to an underdeveloped immune system that overreacts to harmless foods. Pediatric allergy care helps children with food allergies by providing early diagnosis, personalized management plans, and education to prevent allergic reactions and improve overall quality of life. For instance, in January 2026, according to the Centers for Disease Control and Prevention, a US-based public health agency, the percentage of children diagnosed with a food allergy increased to 5.3% in 2024 from 3.5% in 2023. Therefore, the rising incidence of food allergies in children is driving the growth of the pediatric allergy care industry.

Key Players In The Global Pediatric Allergy Care Market

Major companies operating in the pediatric allergy care market are market are AstraZeneca PLC, Thermo Fisher Scientific Inc., Abbott Laboratories, Quest Diagnostics Incorporated, Medicover Woman & Child Hospital, Nemours Children's Health, EUROIMMUN Medizinische Labordiagnostika AG, ALK-Abelló A/S, Stallergenes Greer S.A., Rainbow Children's Hospital, Continental Hospitals, Viracor Eurofins, R-Biopharm AESKU.GROUP GmbH And Co. KG, Apollo Cradle And Children’s Hospital, Hycor Biomedical Inc., AESKU.GROUP GmbH, Ankura Hospital for Women And Children, Nectar Allergy And Asthma, Ann And Robert H. Lurie Children's Hospital of Chicago, DBV Technologies S.A.

Global Pediatric Allergy Care Market Trends and Insights

Major companies operating in the pediatric allergy care market are focusing on developing innovative solutions such as prescription oral immunotherapy (OIT) treatment to desensitize children to allergens and reduce the risk of severe allergic reactions. Prescription oral immunotherapy (OIT) is a medically supervised treatment that gradually exposes patients to small, increasing amounts of an allergen, such as peanuts, to build tolerance and reduce the risk of severe allergic reactions. For instance, in February 2025, Stallergenes Greer International AG, a Switzerland-based biopharmaceutical company, launched Palforzia Oral Immunotherapy (OIT) in the U.S. for children aged 1 to 3 years, expanding its previous indication to include toddlers with confirmed peanut allergies. The therapy consists of defatted peanut allergen powder administered orally through a staged regimen of initial dose escalation, gradual up-dosing, and daily maintenance, designed to reduce allergic reactions, including anaphylaxis, after accidental peanut exposure. Unique aspects include age-specific dosing and use alongside a peanut-avoidant diet to build tolerance. This treatment addresses a critical unmet need in very young children by offering a proactive option beyond avoidance and emergency care, with the potential to modify the natural course of peanut allergy in early childhood.

What Are Latest Mergers And Acquisitions In The Pediatric Allergy Care Market?

In September 2025, Allied Allergy & Asthma, a US-based healthcare services company, acquired the Allergy, Asthma, and Sinus Center for an undisclosed amount. With this acquisition, Allied aims to enhance access to specialized allergy, asthma, and sinus care across Long Island's eight new locations. The Allergy, Asthma, and Sinus Center is a US-based healthcare provider that delivers comprehensive pediatric allergy, asthma, and immunology services for infants, children, and adolescents.

Regional Insights

North America was the largest region in the pediatric allergy care market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Pediatric Allergy Care Market?

The pediatric allergy care market includes revenues earned by entities through prescription allergy medications, allergy testing services, immunotherapy treatments, consultation and clinical services, and nutritional and probiotic supplements. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data And Analysis Are Included In The Pediatric Allergy Care Market Report 2026?

The pediatric allergy care market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pediatric allergy care industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.